Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Decreased fetal movement, Respiratory failure, Akinesia, and Nemaline bodies; and very common findings: Joint stiffness present at birth (arthrogryposis multiplex congenita). 10 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Muscles | 2 | Joint stiffness present at birth (arthrogryposis multiplex congenita), Increased variability in muscle fiber diameter |
NEB encodes nebulin (8,525 aa). This giant muscle protein may be involved in maintaining the structural integrity of sarcomeres and the membrane system associated with the myofibrils. Binds and stabilize F-actin Highest expression in Muscle Skeletal (846.4 TPM) and Heart Atrial Appendage (4.5 TPM).
Arthrogryposis multiplex congenita 6 is associated with mutations in the NEB gene on chromosome 2.
NEB is classified as a druggable target with score 0.0.
Genetic testing for NEB is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for arthrogryposis multiplex congenita 6 has been reported in the published literature.
Phenotype severity distribution: 4 always present features, 1 very common feature, 1 common feature.
No clinical trials have been registered for arthrogryposis multiplex congenita 6.
55 publications have been identified in PubMed for arthrogryposis multiplex congenita 6. Research spans Case Report / Case Series (35%), Review / Meta-Analysis (18%), and Clinical Trial Publication (15%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 19 | 35% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 6:47 AM UTC
Online Mendelian Inheritance in Man
Common questions about arthrogryposis multiplex congenita 6
Pregnancy and birth | 1 | Decreased fetal movement |
Lungs and breathing | 1 | Respiratory failure |
Age of onset: before birth, at birth.
Research summaries
10 |
18% |
Clinical study results | 8 | 15% |
Disease patterns and progression | 7 | 13% |
Laboratory research | 6 | 11% |
Testing and diagnosis research | 4 | 7% |
New treatment approaches | 1 | 2% |
Zgheib O (2026). [PMID: 41562327](https://pubmed.ncbi.nlm.nih.gov/41562327/). *Clin Genet*. [Case Report / Case Series]
Mom A (2026). [PMID: 42161899](https://pubmed.ncbi.nlm.nih.gov/42161899/). *Am J Med Genet C Semin Med Genet*. [Epidemiology / Natural History]
Misceo D (2026). [PMID: 41186962](https://pubmed.ncbi.nlm.nih.gov/41186962/). *Clin Genet*. [Case Report / Case Series]
Maxwell HE (2026). [PMID: 41038248](https://pubmed.ncbi.nlm.nih.gov/41038248/). *Am J Vet Res*. [Clinical Trial Publication]
Kim HH (2026). [PMID: 42139173](https://pubmed.ncbi.nlm.nih.gov/42139173/). *Neonatology*. [Diagnostic / Biomarker]
Meller LLT (2026). [PMID: 41499205](https://pubmed.ncbi.nlm.nih.gov/41499205/). *Endocrinol Diabetes Metab Case Rep*. [Case Report / Case Series]
Ali F (2026). [PMID: 41928479](https://pubmed.ncbi.nlm.nih.gov/41928479/). *Foot Ankle Spec*. [Clinical Trial Publication]
Zidan A (2026). [PMID: 41124586](https://pubmed.ncbi.nlm.nih.gov/41124586/). *Dev Med Child Neurol*. [Diagnostic / Biomarker]
Arduç A (2026). [PMID: 40195522](https://pubmed.ncbi.nlm.nih.gov/40195522/). *Eur J Hum Genet*. [Diagnostic / Biomarker]
Teixeira-Martins R (2025). [PMID: 41269507](https://pubmed.ncbi.nlm.nih.gov/41269507/). *J Ophthalmic Inflamm Infect*. [Case Report / Case Series]